Profile

 

 

Company Name GeneReach Biotechnology Corp.
Stock Name GeneReach
Stock Code 4171
Market Type OTC-Listed
Industry Type Agricultural Biotechnology
Principal Activities Animal Use Medicine Manufacturing / Biotechnology Services / Medical Materials and Equipment Manufacturing / Precision Instruments Manufacturing
Date of Establishment 2004-11-12
Date of OTC 2014-08-14
Capital NT$ 405,900,000 
Chairman Leo Liu
Stock Transfer Agent Fubon Financial Holding Co., Ltd.
Auditors KPMG Taiwan
Principal Office No.19, Keyuan 2nd Rd., Xitun Dist., Taichung City 407, Taiwan
Tel +886-4-24639869
Fax +886-4-24638255
Email genereach@gmail.com

Ownership Structure


2020/04/30
Name of major shareholderNumber of shares held Shareholding ratio (%)
Luveiton Ltd. 3,623,0728.93%
大鑽投資有限公司3,237,4007.98%
趙冠宇3,139,0007.73%
張清泉2,141,0005.28%
中石投資有限公司1,990,4604.90% 
VLB Ltd.1,715,0004.23%
劉正忠1,631,3224.02%
劉品奕994,3482.45%
許俐雅830,5002.05%
劉品岳810,3482.00%

Governance


Executives

 

Chairman of the Board Leo Liu
MSc, Animal Science, Oregon State University
Chief Executive Officer (CEO) Grace Chang Ph.D.
Ph.D., Nutritional Sciences and Toxicology, University of Califonia, Berkeley
Chief Technology Officer Alison Lee Ph.D.
Ph.D., Microbiology, Oregon State University
Chief Commercial Officer Simon Chung
MSc, Animal Science and Biotechnology, Tunghai University
Chief Operation Officer David Tsai Ph.D.
Ph.D., Plant Pathology, National Chung-Hsing University
Vice President of Compliance Operation Yu-Wen Huang
BS, Plant Pathology, National Chung-Hsing University

Organization Structure